Innovative direct dispense technology to ensure in-time delivery and release during continuous biomanufacturing

Register & watch

Tuesday, June 4, 2019
15:00 to 15:45 CEST (Berlin, Paris, Madrid)

In biologic manufacturing, caking is a phenomen that can affect a wide range of hygroscopic solid raw materials and excipients. Apart from the sourcing and logistics considerations for these materials and the direct costs related to caking, lost batches due to unreliable product supply, inconsistent product quality or inconsistent product release are other challenges that companies must overcome.

This webinar will highlight the J.T.Baker® direct dispense platform, an innovative packaging technology for the storage and dispensing of pre-weighed solid raw materials and excipients.

Topics include:

  • Large scale biopharmaceutical manufacturing challenges and opportunities
  • Improvements in flexibility and process economics through continous and single system based process offers
  • Case study: how the J.T.Baker® direct dispense platform aided a customer in de-clumping material in their buffer preparation

Register & watch

Presented by:

Willie Hesselink

Willie Hesselink is a Senior Technical Application Project Manager at Avantor. Prior to this role, he was a R&D Manager at Avantor Performance Materials in Deventer, Netherlands.

Willie brings over 20 years of industrial expertise in the research and development of raw materials and excipients used in the different steps of biopharmaceutical processes. In his current role working within Avantor's biopharma production business unit, he has lead many process optimization and cost reduction projects in collaboration with customers. Willie holds a B.Sc. in analytical chemistry from the Saxion University of Applied Sciences in Enschede, Netherlands.

Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. One of our greatest strengths comes from having a global infrastructure that is strategically located to support the needs of our customers. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world.